Explore the individual investment experience of the partners.
Together, we are building the next chapter of Cove at Seed and Series A.
We are bringing together complementary investing and operating experience to build an early-stage venture platform for the next generation of founders.
Contact the team →| Company | Sector | Initial Inv Date | Total Inv. | FMV | MOIC | Status | Notes / Outcome |
|---|---|---|---|---|---|---|---|
| Content.One (Zesty.io)Content management & web platform | SaaS / MarTech | 11/2021 | $500K | $632K | 1.26x | Active | Note + equity · $2.3M ARR · marked at ~$632K · potential M&A path |
| iCardioAI-powered cardiac imaging | HealthTech / AI | 3/2026 | $500K | $500K | 1.00x | Active · New | Series Seed · March 2026 · held at cost |
| 3Laws RoboticsCalTech robotics safety software | Deep Tech / AI | 9/2024 | $500K | $895K | 1.79x | Amazon Acquisition | ~1.8x · ~41% IRR · closed Q2 2026 |
| XiloInsurance quoting & sales automation | InsurTech / SaaS | 8/2022 | $770K | $1.07M | 1.39x | Portfolio Leader | $5.5M ARR ($600K ahead of plan) · 130% NRR · Brown & Brown closed Feb · AI Quoting Agent launched · path to $10M ARR → Series B |
| Carro / VYRLCollaborative commerce / dropship | eCommerce / B2B | 9/2025 | $1.50M | $1.54M | 1.03x | Breakout · $1B GMV | $6.8M → $105.6M GMV · 149x growth in 18 mo · profitable · on track for $1B/yr run-rate July 2026 |
| BLNGJewelry intelligence platform · B2B SaaS | eCommerce / AI | 2/2025 | $1.05M | $1.05M | 1.00x | Breakout Quarter | David Yurman $1M/yr (largest enterprise deal) · Tiffany in final negotiations · Rolex pilot · Signet sole-vendor (2,000-store) · Seed II co-led by Cove & SpeedInvest |
| Quantum ElementsQuantum digital twin software | Deep Tech / Quantum | 3/2026 | $750K | $750K | 1.00x | Technical + Commercial Breakout | World's largest hardware-faithful quantum digital twin w/ AWS · Nature Comms paper · SAFE oversubscribed $2.8M · 49-month runway |
| SigmaSightLitigation intelligence · B2B SaaS | LegalTech / AI | 12/2024 | $1.36M | $1.36M | 1.00x | Strong Traction | $500K ARR (Mitsui) · enterprise contract signed · Series A prep |
| OccuspaceSpace utilization analytics | PropTech / AI | 8/2023 | $850K | $1.15M | 1.36x | Portfolio Leader | $3.33M CARR (+52% YoY) · 5-yr $41.9M GSA contract active · Notre Dame, LSU & Kaiser wins · bridging to Q3 '27 breakeven |
| VisaicImmersive fan experience platform | Media / Sports Tech | 5/2024 | $750K | $867K | 1.16x | Strong Growth | $1.5M gross revenue (+63% YoY) · MidCo Sports signed Jan (largest customer) · Black Bear early 5-yr renewal |
| VECKTAEnergy transition marketplace | ClimateTech / Marketplace | 6/2022 | $825K | $833K | 1.01x | Series A Signed | 2.3x pro forma · Series A signed, pending close |
| Eira BioOncology & women's health therapeutics | BioTech / Oncology | 11/2025 | $250K | $250K | 1.00x | Solid Execution | Lead prostate cancer program on track for dev candidate by year-end · preeclampsia program advancing · 16 FTEs · on budget |
| MelioCulture-free blood pathogen detection | MedTech / Diagnostics | 5/2024 | $500K | $500K | 1.00x | Fundraising | $3.5M CARBEX grant · Series A in market |
| Time MachineAI onboarding & training for sales teams | AI / B2B SaaS | 9/2025 | $500K | $519K | 1.04x | Active | $300K ARR · 30 customers · Series A prep |
| CelitechWhite-label eSIM for travel operators | TelecomTech / B2B2C | 6/2022 | $625K | $745K | 1.19x | Active | Cove-led seed · Series A prep |
| CenfireFabless semiconductor · MEMS relay tech | Semiconductors / Deep Tech | 1/2026 | $500K | $500K | 1.00x | Seed-2 | Silicon MEMS relay tech (no metal fatigue) · $3.3M Seed-2 at $10.9M pre · initial market T&M/ATE · ~$15B SAM |
| WethosFreelancer team-building & pricing | Future of Work / SaaS | 7/2024 | $500K | $500K | 1.00x | Fundraising | Raising $20M+ Series A at $100M+ valuation |
| ExokeryxExtracellular vesicle extraction | BioTech / Diagnostics | 7/2024 | $500K | $500K | 1.00x | Watch — Tight Timeline | First product revenue · cash through September · hiring frozen · Series A on hold pending revenue |
| CARI HealthReal-time medication monitoring | HealthTech | 7/2022 | $500K | $250K | 0.50x | Written Down 50% | Pivot in progress · bridge underway |
| GroGuruPrecision agriculture soil intelligence | AgTech | 6/2023 | $600K | $100K | 0.17x | Written Off | $100K secured note repaid |
| Company | Val. at LaunchPad | Latest Post-Money | Val. Growth | Outcome |
|---|---|---|---|---|
| DTx PharmaRNA therapeutics · San Diego | $6M | $1.10B (Novartis acq.) | 183.3x | Acquired · Novartis |
| HypericeRecovery tech · Irvine, CA | $8M | $850M (Series B) | 106.3x | Active · Series B |
| AcornsConsumer fintech | $9M | $870M | 96.7x | Active |
| SentryCardPayment security fintech | $12M | $150M | 12.5x | Active |
| Neural AnalyticsBrain health diagnostics | $7.7M | $93M | 12.1x | Active |
| NGD SystemsStorage semiconductor | $22.6M | $106M | 4.7x | Active |
| SonendoDental MedTech | $74.3M | $500M+ | 6.7x+ | IPO · NYSE: SONX |
| RxSightAdjustable intraocular lenses · Aliso Viejo, CA | n/a | n/a | n/a | IPO · Nasdaq: RXST |
| LensGenOphthalmology devices | $19.2M | $76.2M | 4.0x | Active |
| Recros MedicaWound care / injectables | $20M | $45M | 2.3x | Active |
| MavenlinkPSA software | $61.4M | $235M | 3.8x | Merged · Kantata |
| BontiBotulinum toxin biotech | $22.3M | $195M | 8.8x | Acquired · Allergan |
| EnevateEV battery technology | $44.1M | $251M | 5.7x | Active |
| # | Company | Category | Initial Inv Date | Round | Initial Inv. | Total Inv. | FMV | MOIC | IRR | Role | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | YassirMENA super app — ride-hailing, delivery & fintech | Consumer Marketplace | 10/2025 | Series C | $40.0M | $40.0M | $82.7M | 2.1x | 200.5% | Co-Led | Active |
| 2 | PrezentAI-powered business presentation platform | Enterprise Software | 9/2025 | Series B | $12.5M | $20.7M | $38.1M | 1.8x | 20.5% | Co-Led B, Board Obs. | Structured & facilitated Prezent's acquisition of Prezentium, coinciding with the Series B fundraise |
| 3 | RampCorporate spend — cards, bill pay & expense software | Enterprise Software / Fintech | 9/2025 | Series E-2 | $10.0M | $12.7M | $22.7M | 1.8x | 154.2% | Co-Led | Late-stage entry; strong markup over a short hold |
| 4 | HumanitecDevOps platform for app delivery & infrastructure orchestration | Enterprise Software | 7/2025 | Seed | $1.8M | $1.8M | $0.0M | 0.0x | 0.0% | Co-Led Seed T2 | Early-stage seed position; marked to $1 |
| 5 | WhatnotLive-shopping marketplace for collectibles | Consumer Marketplace | 5/2023 | Secondary | $15.0M | $15.0M | $65.7M | 4.4x | 61.5% | Co-Led Initial | Reflects Growth IV position only; does not include additional SPV |
| 6 | BetterflyBenefits & wellbeing platform with healthy-habit rewards | Enterprise Software | 1/2022 | Series C | $15.0M | $15.0M | $15.0M | 1.0x | 0.0% | Sourced, Led, Board Obs. | Active — marked at cost |
| 8 | CitizenReal-time public-safety app for nearby incident alerts | Consumer SaaS | 5/2020 | Series B | $1.0M | $29.9M | $33.5M | 1.1x | 2.7% | Sourced, Co-Led | Significant follow-on capital deployed; modest returns to date |
| 9 | LightricksCreator software — photo/video editing & content production | Consumer SaaS | 7/2019 | Series C | $18.4M | $20.2M | $30.3M | 1.5x | 6.2% | Sourced, Co-Led | Creator-economy play; solid appreciation over a multi-year hold |
| 13 | Deposit SolutionsDeposits marketplace — connects banks with savers | Fintech | 7/2016 | Series B | $7.7M | $14.1M | $46.5M | 3.3x | 15.2% | Co-Led | Merged with Raisin; holding position in combined company. FMV includes $17.6M realized proceeds |
| 15 | Thrive MarketMembership e-commerce for healthy products | Consumer / Subscription | 7/2015 | Series A | $5.3M | $12.8M | $59.2M | 4.6x | 16.6% | Co-Led Series A | Decade-long hold since 2015; durable membership model; strong appreciation |
| # | Company | Category | Initial Inv Date | Exit | Initial Inv. | Total Inv. | Proceeds | MOIC | IRR | Role | Exit Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | SemrushDigital marketing & SEO platform | Enterprise Software | 3/2018 | 4/2026 | $10.7M | $18.1M | $159.6M | 8.8x | 42.8% | Co-Led, Board Obs. | Partial exit Nov 2021 post-IPO. Later acquired by Adobe for $1.9B; full exit Apr 2026 |
| 12 | ComparablyEmployee insights & workplace benchmarking | Enterprise Software | 1/2017 | 5/2022 | $3.3M | $4.3M | $18.7M | 4.4x | 36.1% | Sourced, Co-Led | Acquired by ZoomInfo for $150M in May 2022 |
| 14 | ScopelyMobile game publisher & developer | Consumer / Gaming | 4/2016 | 4/2023 | $17.2M | $20.0M | $73.6M | 3.7x | 20.0% | Co-Led Series B | Acquired by Savvy Games Group for $4.9B in Apr 2023. Reflects Series B investment only |
| 11 | AxiosNews & media — concise coverage & newsletters | Publishing | 12/2017 | 8/2022 | $5.4M | $5.4M | $19.6M | 3.6x | 32.4% | Co-Led | Acquired by Cox for $525M in August 2022 |
| 7 | ElevateBenefits platform for HSAs, FSAs, HRAs & other accounts | Enterprise Software | 7/2021 | 1/2025 | $5.0M | $11.3M | $14.8M | 1.3x | 9.3% | Sourced | Benefits administration platform; realized Jan 2025 |
| Realized Total | $41.6M | $58.9M | $286.2M | 4.9x | — | ||||||
| Company | Sector | Initial Inv Date | Total Inv. | Status | MOIC | Key Notes |
|---|---|---|---|---|---|---|
| AbridgeAI clinical documentation | Health AI / Infrastructure | 7/2023 | $2.0M | Breakout | 12.4x | $5.3B valuation · 150+ health system partners · $110M+ ARR · $4.48M partial liquidity realized · QSBS eligible |
| ArtisightSmart hospital platform | Health AI / Platform | 10/2024 | $21.5M | Scaling | ~1.0x | $5M initial + $16.5M conviction follow-on · smart hospital OS · HaaS transition · deep Epic & Microsoft integrations · Board guest |
| Sprinter HealthMobile care delivery | Digital Health | 2/2024 | $10.65M | Breakout | ~2.0x | $45M revenue (2025), tracking $100M+ · $55M Series B · a16z, General Catalyst & GV · 96% patient satisfaction |
| Bright UroMinimally invasive urology | MedTech / Diagnostics | 5/2024 | $7.0M | Scaling | 1.6x | FDA 510(k) cleared · 30+ clinics · capital-efficient device model · $5M follow-on reflects conviction · Board guest |
| ViaLaseOphthalmic laser | MedTech / Ophthalmology | 7/2024 | $6.13M | Late-Stage | 1.0x | $5.0M initial + $1.13M follow-on · near-term EU commercialization pathway · regulatory de-risking underway · late-stage optionality |
| Horizon SurgicalRobotic ophthalmology | MedTech / Robotics | 6/2024 | $5.0M | Clinical | 1.0x | Approaching first-in-human · asymmetric upside tied to clinical inflection |
| Vital BioNext-gen diagnostics | Diagnostics / Platform | 10/2024 | $5.0M | Platform | 1.0x | Strategic partnership with Sysmex · long-term platform play with strong institutional backing |
| PerceptiveClosed-loop ICU automation | Health AI / Critical Care | 12/2022 | $4.0M | Development | 1.0x | NIH-supported · strong technical validation · IDE submission in progress · large TAM · Board observer |
| PrenosisAI sepsis platform | Health AI / Diagnostics | 6/2025 | $2.0M | Scaling | 1.0x | FDA-cleared AI sepsis platform · Roche distribution partnership · strong clinical validation · Board observer |
| CodaMetrixAI revenue cycle | Health AI / RCM | 6/2025 | $2.0M | Scaling | 1.0x | 220+ health system sites · validated enterprise adoption · deployed within the sponsoring health system |
| BionautMicro-robotics drug delivery | DeepTech / Biotech | 5/2024 | $2.0M | Impaired | — | Program risk materialized · clinical timelines extended · disciplined loss recognition / capital preservation |
| Eira BioEarly-stage biotech | Biotech / Therapeutics | 10/2025 | $0.25M | New | 1.0x | Venrock-led $20M round at $40M valuation · strong institutional validation |
| DelixNeuroplastogen platform | Life Sciences / Neuro | 6/2025 | $0.2M | Optionality | 1.0x | Strategic option via Eli Lilly partnership (~$870M potential) · early-stage positioning |
